surfact
protein
patternrecognit
molecul
belong
collectin
famili
group
collagencontain
ctype
lectin
human
collectin
also
includ
surfact
protein
spa
tissu
distribut
function
partial
overlap
spd
one
main
effect
spd
aggreg
enhanc
phagocytosi
microb
die
host
cell
addit
classic
member
collectin
famili
serum
protein
mannanbind
lectin
mbl
evok
complement
activ
lectin
pathway
complex
mblassoci
serin
proteas
masp
moreov
three
novel
human
defens
collagen
collectin
liver
collectin
kidney
collectin
placenta
identifi
partli
heterocomplex
one
anoth
found
circul
associ
masp
induc
complement
activ
differ
collectin
type
ii
membran
protein
fluid
phase
variant
scaveng
receptor
well
complement
activ
function
pulmonari
surfact
multimolecular
complex
consist
phospholipid
cholesterol
total
surfact
protein
surfact
protein
consist
highmolecular
weight
hmw
hydrophil
protein
spa
spd
lowmolecular
weight
lmw
extraordinarili
lipophil
surfact
protein
b
spb
surfact
protein
c
spc
essenti
biophys
properti
surfact
phospholipid
surfact
protein
local
lung
nonpulmonari
tissu
protein
associ
extern
lumin
surfac
respiratori
digest
glandular
reproduct
tract
urinari
vascular
epithelia
gland
tabl
consist
role
spd
pattern
recognit
major
locat
express
interfac
extern
milieu
plasma
urin
tear
cerebrospin
fluid
amniot
fluid
mainten
steril
milieu
critic
spd
express
nonpulmonari
site
may
produc
surfactantlik
materi
phospholipid
lubric
present
numer
distinct
site
major
function
spd
lung
regul
pulmonari
surfact
lipid
level
although
investig
specul
spd
may
also
particip
phospholipid
homeostasi
extrapulmonari
site
moreov
spd
express
muscl
cell
endothelium
cardiovascular
system
suggest
function
inhibitor
inflammatori
signal
express
pattern
spd
frequent
valid
differ
observ
use
divers
techniqu
tabl
spd
immunostain
also
observ
infiltr
white
blood
cell
exampl
lung
placenta
moreov
spd
immunestain
detect
phagolysosom
compart
granular
stain
cell
membran
ultrastructur
studi
demonstr
presenc
spd
endocyt
compart
rat
alveolar
macrophag
biosynthet
organel
indic
spd
produc
inflammatori
cell
rather
taken
endocytosi
proxim
promot
spd
mediat
cell
typerestrict
basal
glucocorticoidstimul
promot
activ
demonstr
vitro
spd
promot
origin
identifi
contain
multipl
potenti
cisregulatori
element
includ
halfsit
glucocorticoid
respons
element
canon
consensu
sever
sequenc
ebox
sequenc
sever
cebp
motif
put
interferon
respons
element
foxabind
site
gtcontain
regulatori
element
regulatori
role
junb
jund
cjun
cfo
gtbox
bind
protein
identifi
mutat
studi
suggest
permiss
glucocorticoid
regul
spd
express
caus
increas
promot
occup
furthermor
retinoblastoma
protein
demonstr
stimul
sftpd
gene
activ
form
complex
cebp
bound
consensu
site
sftpd
promot
moreov
calcineurinnfat
pathway
demonstr
activ
vitro
result
assembl
nfat
transcript
complex
proxim
promot
mous
sftpd
mitogenactiv
protein
kinas
mapk
mediat
upregul
spd
express
report
human
corneal
epitheli
cell
human
lung
epitheli
cell
expression
regul
mediat
via
signal
jnk
mapk
express
spd
corneal
epithelium
inhibit
pharmacolog
inhibitor
tolllik
receptor
tlr
myeloid
differenti
primari
respons
gene
signal
tumor
necrosi
significantli
augment
level
spd
express
primari
coronari
endotheli
cell
moreov
basal
level
spd
reduc
nitric
oxid
synthas
inhibitor
lname
inhibitor
phosphoinositid
wortmannin
inhibitor
activ
map
kinas
cascad
pd
invers
spd
express
could
increas
deta
nonoat
donor
insulin
activ
surfact
protein
express
development
regul
regul
epigenet
allelespecif
express
outsid
lung
dexamethason
treatment
cultur
fetal
lung
explant
increas
spd
mrna
protein
matern
steroid
treatment
increas
fetal
serum
spd
vitro
vivo
studi
confirm
regul
spd
express
glucocorticoid
shown
dramat
increas
prior
birth
fetal
lung
matur
occur
exposur
glucocorticoid
simultan
increas
express
spd
lung
epitheli
cell
vivo
studi
demonstr
increas
spd
mrna
pharmacolog
inhibit
dipeptidyl
peptidas
activ
mrna
protein
brief
oxygen
exposur
rat
mrna
protein
markedli
increas
follow
mous
exposur
cytokin
interleukin
il
wherea
insulin
report
inhibit
spd
express
lung
epitheli
cell
line
addit
estrogen
posit
regul
express
spd
mous
uteru
progesteron
along
estrogen
synerg
spd
express
howev
administ
alon
result
neg
regul
spd
transcript
level
increas
sevenfold
prostat
castrat
rat
suggest
neg
regul
testosteron
testosteron
suppress
downregul
transcript
level
spd
murin
testi
moreov
serum
spd
level
increas
turner
syndrom
patient
treat
growth
hormon
primari
report
effect
spd
includ
bind
bacteria
virus
fungi
recent
helminth
parasit
clearanc
via
opson
phagocyt
recognit
detail
review
numer
interact
spd
pathogen
microb
provid
nayak
et
al
spd
also
bind
biolog
abiot
particl
particip
clearanc
airway
potenti
addit
site
henc
spd
known
aggreg
allergen
aid
remov
enhanc
clearanc
genom
dna
apoptot
materi
aggreg
remov
particul
materi
capac
affect
mous
intestin
microbiota
certain
experiment
condit
lectin
activ
human
spd
favor
interact
microbi
ligand
glycosyl
varieti
saccharid
includ
nacetylmannosamin
mannac
mannos
fucos
howev
spd
also
recogn
bind
wide
rang
inhal
pathogen
bind
saccharid
well
lipid
nucleic
acid
broad
specif
initi
phagocytosi
divers
ligand
interact
recent
review
jakel
et
al
addit
opson
phagocytosi
antimicrobi
effect
spd
includ
aggreg
may
enhanc
effici
neutrophil
extracellular
trap
bacteri
fungal
cellmembran
lysi
neutral
infect
dampen
innat
signal
evok
microbederiv
ligand
surfact
protein
enhanc
phagocytosi
addit
antimicrobi
activ
benefici
host
howev
rare
case
spd
bind
pathogen
risk
factor
contribut
deterior
murin
diseas
increas
pathogen
burden
exampl
hypocapsular
cryptococcu
neoforman
pneumocysti
carinii
initi
studi
spd
interact
mycobacterium
tuberculosi
demonstr
reduc
bacteri
uptak
macrophag
wherea
vivo
studi
suggest
spd
dispens
immun
control
infect
wealth
data
vitro
studi
demonstr
spd
modul
immun
cell
epitheli
cell
fibrocyt
smooth
muscl
cell
function
tabl
initi
spd
demonstr
interact
manner
glycosyl
via
ctype
lectin
domain
ctld
therebi
inhibit
lipopolysaccharid
lp
bind
subsequ
allergeninduc
activ
macrophag
dendrit
cell
spd
mediat
suppress
signal
pathway
discov
furthermor
spd
inhibit
cell
surfac
bind
lp
cell
attenu
bind
lp
ctld
moreov
spd
modul
epitheli
respons
addit
microbi
stimuli
recent
document
depend
observ
may
partial
explain
result
vivo
studi
indic
spd
inhibit
inflamm
caus
bacteri
lp
spd
also
bind
highli
cite
studi
suggest
free
spd
bind
cellular
receptor
ctld
result
inhibitori
signal
prevent
activ
mononuclear
phagocyt
nuclear
activ
secret
inflammatori
cytokin
signal
contrast
ctld
occupi
ligand
spd
suggest
interact
cell
surfac
receptor
complex
consist
calreticulin
collagenlik
domain
promot
inflammatori
cell
activ
howev
main
focu
studi
spa
interact
consequ
evid
direct
bind
weak
interact
demonstr
spa
studi
inspir
research
valid
bind
spd
nglycosyl
site
membraneproxim
domain
relat
sirp
moreov
absenc
inflamm
spd
suppress
phagocyt
function
alveolar
macrophag
bind
therebi
alter
activ
downstream
signal
effector
contrast
lpsinduc
inflamm
recruit
mononuclear
phagocyt
partli
escap
spdmediat
inhibit
contribut
cell
clearanc
product
suppress
glucocorticoid
treatment
reliev
spddriven
suppress
apoptot
cell
uptak
downregul
time
spd
interact
valid
demonstr
interact
spd
macrophag
calreticulin
appear
depend
biochem
modif
spd
snitrosothiol
sno
spd
form
nitrosyl
ntermin
cystein
spd
nativ
spd
chemoattract
macrophag
induc
downstream
phosphoryl
author
suggest
spd
act
integr
statu
lung
line
initi
inflammatori
respons
variou
patholog
condit
calreticulinmedi
signal
maintain
quiescent
state
signal
absenc
stress
leukocyteassoci
immunoglobulinlik
receptor
receptor
express
immun
cell
collagen
highaffin
ligand
inhibitori
spd
receptor
collagen
stalk
spd
essenti
interact
result
function
reduct
reactiv
oxygen
speci
ro
signal
neutrophil
cell
line
author
therefor
suggest
lack
interact
could
respons
increas
product
hydrogen
peroxid
lung
homogen
previous
observ
spd
defici
mice
anoth
collagen
receptor
oscar
express
inflammatori
cc
chemokin
receptor
type
monocyt
macrophag
function
interact
multimer
cruciform
spd
result
proinflammatori
respons
interact
lead
releas
monocyt
appar
intern
spdoscar
complex
alveolar
macrophag
oscar
also
express
osteoclast
dendrit
cell
endotheli
cell
surfact
protein
bind
eosinophil
detect
flow
cytometr
analysi
may
explain
inhibitori
effect
spd
igg
serumtrigg
eosinophil
cation
protein
degranul
eosinophil
mice
reduc
express
pulmonari
expos
ozon
therefor
hypothes
natur
killer
nk
cell
interact
spd
glycosyl
membran
receptor
indirect
evid
interact
came
reduc
bind
spd
nk
cell
obtain
mice
rel
mice
author
studi
suggest
interact
may
involv
impair
dendrit
cell
home
lymphoid
tissu
mice
phenotyp
ighepta
defici
mice
similar
mice
includ
accumul
surfact
lipid
enlarg
alveoli
hypertrophi
type
ii
alveolar
atii
cell
decreas
surfact
uptak
type
ii
alveolar
cell
atii
cell
accumul
enlarg
foami
macrophag
enhanc
express
matrix
metalloproteinas
gene
therefor
hypothes
adhes
class
g
proteincoupl
receptor
may
interact
spd
highli
express
type
ii
pneumocyt
immunoprecipit
flagtag
recombin
protein
support
spd
like
ligand
receptor
uroplakin
ia
glycoprotein
express
bladder
urothelium
serv
receptor
fimh
lectin
bacteri
pili
interact
initi
uropathogen
escherichia
coli
upec
infect
spd
bind
directli
upia
rich
high
mannos
glycan
therebi
inhibit
adher
cytotox
upec
human
bladder
epitheli
cell
line
vitro
observ
support
result
experi
demonstr
exogen
administr
spd
inhibit
upec
adher
bladder
dampen
upecinduc
inflamm
mice
surfact
protein
bind
directli
high
mannosetyp
nglycan
egfr
interact
block
bind
epiderm
growth
factor
egf
egfr
suppress
egf
signal
inhibit
prolifer
migrat
two
human
lung
adenocarcinoma
epitheli
cell
line
indic
lung
cancer
cell
regul
spd
via
autocrin
mechan
addit
receptor
candid
sim
demonstr
spd
bind
structur
macrophag
dendrit
cell
calciumdepend
manner
howev
unabl
identifi
natur
structur
interact
spd
dendrit
cellspecif
intercellular
adhes
nonintegrin
reduc
spdmediat
captur
transfer
cell
secret
host
molecul
report
bind
spd
includ
decorin
proteas
inhibitor
alpha
macroglobulin
enhanc
bacteri
agglutin
protect
spd
elastasemedi
degrad
delet
malign
brain
tumor
enhanc
spdmediat
viral
aggreg
defensin
accord
subtyp
may
caus
spd
precipit
bronchoalveolar
lavag
bal
fluid
addit
viral
neutral
activ
combin
spd
moreov
variou
class
immunoglobulin
includ
igg
igm
ige
secretori
iga
bind
spd
spd
aggreg
immunoglobulinco
bead
enhanc
phagocytosi
complex
effect
opson
late
apoptot
cell
enhanc
clearanc
alveolar
macrophag
lung
amino
acid
sequenc
aa
matur
spd
monom
consist
four
structur
domain
ntermin
domain
involv
intermolecular
disulfid
bond
format
collagen
domain
import
space
ctld
neck
region
involv
protein
trimer
space
ctld
globular
ctermin
ctld
figur
respons
bind
microbi
ligand
spd
protein
structur
stabil
assembl
trimer
multim
via
two
conserv
cystein
residu
ntermin
domain
individu
arm
length
spd
monom
approxim
nm
make
molecul
dimens
order
magnitud
certain
virus
shown
electron
microscopi
molecular
mass
spd
molecul
rang
kda
consequ
differ
degre
multimer
disulfidebridg
depend
trimer
spd
subunit
multimer
cruciform
fuzzibal
structur
astral
bodi
contain
trimer
subunit
figur
provid
spatial
arrang
requir
highavid
interact
ctld
multival
microbi
ligand
effect
spd
thu
depend
degre
multimer
bind
ligand
figur
cellular
receptor
evok
major
spd
antimicrobi
effect
highmolecular
weight
spd
multim
partli
depend
disulfid
crosslink
ntermini
proport
spd
subunit
noncoval
associ
allow
interconvers
hmw
spd
lmw
spd
trimer
demonstr
use
size
permeat
chromatographi
figur
hmwlmw
ratio
depend
concentr
protein
solut
lowprotein
concentr
favor
decomposit
multim
trimer
addit
hmwlmw
ratio
increas
affin
purif
spd
suggest
ligandbind
facilit
assembl
spd
trimer
multim
singlenucleotid
polymorph
snp
spd
gene
sftpd
result
express
either
methionin
threonin
posit
matur
protein
hmwlmw
ratio
bodi
fluid
appear
vari
accord
amino
acid
posit
methionin
threonin
allel
variant
assess
monoclon
immunodetect
spd
ctld
size
permeat
chromatographi
hmw
spd
exhibit
markedli
increas
bind
major
microbi
ligand
microb
call
question
role
lmw
spd
larg
reservoir
subunit
avail
assembl
hmw
spd
enrich
microbi
surfac
howev
wherea
hmw
spd
bind
preferenti
intact
influenza
viru
bacteria
trimer
spd
favor
bind
isol
bacteri
lp
use
mannacaffin
chromatographi
place
tradit
maltoseaffin
chromatographi
allow
prepar
enrich
natur
trimer
human
spd
facilit
investig
molecul
natur
lmw
spd
also
bind
endogen
circul
ligand
includ
lowdens
lipoprotein
ldl
oxid
ldl
oxldl
highdens
lipoprotein
hdl
partial
manner
wherea
hmw
spd
bind
lipoprotein
transgen
mice
express
either
human
spd
allel
variant
gener
test
hypothesi
allel
variat
implic
diseas
howev
express
allel
variant
control
promot
ubiquit
express
consequ
distribut
spd
level
lung
serum
appear
differ
endogen
spd
made
comparison
effect
normal
mice
difficult
despit
sustain
alleledepend
hmwlmw
spd
distribut
low
transgen
express
level
lung
gener
pulmonari
phenotyp
transgen
mice
somewhat
resembl
sftpd
defici
character
mild
emphysema
presenc
foam
celllik
macrophag
altern
studi
made
point
mutat
affect
ntermin
cystein
involv
stabil
spd
hmw
multim
delet
collagen
region
andor
ntermin
region
studi
demonstr
trimer
spd
subunit
saccharid
select
multim
appear
weaker
restrict
rang
antimicrobi
activ
vivo
studi
ntermin
cystein
mutat
spd
overexpress
spd
collagen
delet
mutant
protein
express
wildtyp
mice
demonstr
nativ
spd
essenti
pulmonari
phospholipid
homeostasi
prevent
airspac
enlarg
collect
studi
suggest
multimer
import
howev
vivo
administr
repeat
high
dose
recombin
trimer
fragment
spd
recombin
trimer
fragment
spd
lack
ntermin
retain
part
collagen
region
rfhspd
lack
nterminu
retain
part
collagen
region
appear
similar
effect
nativ
spd
reduc
lipidosi
apoptot
macrophag
alveolar
type
ii
cell
number
airspac
enlarg
mice
suggest
homeostat
effect
spd
predominantli
mediat
ctld
high
therapeut
level
trimer
human
spd
may
compens
rel
low
target
avid
trimer
rfhspd
subsequ
use
success
antimicrobi
antiinflammatori
therapi
seri
vivo
studi
also
induc
apoptosi
activ
immun
cell
howev
rfhspd
also
fail
demonstr
effect
context
extent
effect
fulllength
multimer
spd
mimick
high
level
trimer
spd
yet
entir
clear
accord
studi
adult
twin
genet
factor
explain
estim
variat
constitut
serum
spd
level
moreov
sftpd
snp
associ
serum
level
spd
explain
phenotyp
variat
allel
variant
associ
highest
level
allel
variant
detect
rel
high
frequenc
north
european
popul
moreov
allel
frequenc
distribut
highli
similar
differ
popul
although
ethnic
differ
document
consist
genet
determin
spd
level
constitut
distribut
hmw
lmw
spd
human
bodi
fluid
also
genet
determin
individu
homozyg
allel
rel
predomin
hmw
spd
allel
homozygot
lmw
spd
depend
spd
molecular
size
genet
variat
support
size
distribut
recombin
spd
express
two
allel
variant
human
cell
line
vari
abil
allel
variant
assembl
multim
postul
attribut
differ
hydrophob
properti
met
thr
partial
olink
glycosyl
may
affect
closeproxim
disulfid
bond
thu
limit
stabil
multim
sever
studi
link
clinic
patholog
tabl
may
indic
involv
spd
size
variat
pathogenesi
associ
studi
demonstr
strong
interact
smoke
includ
preclin
cardiovascular
diseas
cvd
moreov
data
contradictori
exampl
snpanalysi
associ
variat
chronic
obstruct
pulmonari
diseas
copd
wherea
genomewid
associ
gwa
analysi
confirm
associ
although
sever
sftpd
snp
identifi
associ
copd
recent
associ
variat
spd
size
variat
report
respiratori
diseas
howev
overal
conclus
studi
variant
associ
allel
variant
may
deleteri
differ
diseas
context
although
major
studi
suggest
diseas
associ
allel
surfact
protein
undergo
olink
glycosyl
variant
essenti
present
trimer
form
moreov
endotheli
spd
appear
lower
molecular
weight
band
pattern
sdspage
may
repres
immatur
intracellular
protein
posttransl
modifi
version
spd
differ
form
produc
lung
cell
cell
gener
spd
amniot
fluid
howev
remain
explor
one
type
diseaseinduc
modif
spd
suggest
increas
level
core
fucos
spd
nglycan
nglycan
expect
affect
quaternari
structur
spd
normal
spd
nglycan
compris
core
fucos
howev
glycosyl
partial
depend
fucosyltransferas
activ
glycom
analysi
demonstr
level
corefucosyl
nglycan
spd
increas
rel
total
spd
smoke
copd
subject
nonsmok
two
ntermin
cystein
posit
spd
ntermin
region
implic
induc
nitric
oxid
synthas
ino
nomedi
control
multimer
spd
format
snitrosothiol
spd
snospd
snospd
level
increas
inflamm
format
result
decomposit
spd
multim
radiationinduc
lung
injuri
thu
report
result
inosdepend
disrupt
spd
multim
mous
bal
describ
earlier
snospd
spd
neither
multimer
trimer
chemoattract
macrophag
induc
cellular
phosphoryl
indic
snospd
react
differ
cellular
receptor
compar
spd
nonreduc
crosslink
hmw
spd
occur
normal
late
amniot
fluid
bal
alveolar
proteinosi
asthma
patient
bal
provoc
allergen
format
tyrosinedepend
coval
crosslink
within
neckctld
spd
result
reactiv
oxid
speci
ro
includ
peroxynitrit
activ
reduc
spd
ligand
aggreg
addit
oxid
damag
caus
neutrophil
myeloperoxidas
specif
reactiv
oxid
product
hypochlor
acid
hypochlor
acid
caus
abnorm
reduc
ntermin
disulfid
crosslink
spd
although
mechan
fulli
elucid
modif
result
loss
aggreg
activ
spd
vitro
context
acut
inflamm
vivo
surfact
protein
subject
divers
type
proteolyt
degrad
result
releas
lmw
breakdown
product
kda
variou
studi
demonstr
spd
fragment
human
lung
relev
enzym
includ
host
proteas
neutrophil
elastas
cathepsin
g
proteas
along
elastas
produc
pseudomona
aeruginosa
hous
dust
mite
proteas
clinic
relev
proteolyt
degrad
spd
observ
differ
set
includ
acut
lung
injuri
ali
cystic
fibrosi
cf
bal
spd
degrad
cf
relev
proteas
well
describ
neutrophil
elastas
appear
import
contributor
reduc
ctld
lectin
activ
spd
vitro
howev
function
consequ
question
physiolog
concentr
calcium
delay
abolish
spd
proteolysi
studi
shown
although
present
proteolyt
fragment
spd
appear
respons
reduc
spd
lectin
activ
cf
instead
suggest
mediat
oxid
modif
nevertheless
spd
level
decreas
elastaseposit
cf
bal
sampl
depress
level
gener
suggest
result
proteolyt
activ
clinic
spd
defici
document
howev
bal
level
spd
may
decreas
diseas
level
prevent
immunodetect
surfact
protein
breakdown
product
also
detect
sampl
obtain
patient
sever
asthma
one
recent
studi
breakdown
product
detect
western
blot
wb
bal
wherea
author
succeed
identifi
breakdown
product
serum
strataclean
incub
step
detect
breakdown
product
correl
increas
enzymelink
immunosorb
assay
elisa
base
detect
serum
spd
expens
bal
spd
henc
elisa
readout
may
repres
mixtur
complet
degrad
spd
form
lmw
spd
breakdown
product
togeth
trimer
spd
nonreduc
spd
separ
size
permeat
chromatographi
wb
demonstr
use
bal
obtain
children
gastroesophag
reflux
serum
patient
asthma
loss
barrier
integr
respons
outward
intravascular
leakag
secret
lung
protein
inward
edemat
flood
interstitium
air
space
concentr
gradient
spd
thu
allow
spd
synthes
respiratori
tract
leak
bloodstream
acut
chronic
lung
injuri
follow
cigarett
smoke
exposur
demonstr
use
mice
shown
human
subject
thu
set
includ
acut
cigarett
smoke
exposur
spd
may
decreas
bal
simultan
enrich
serum
smoke
statu
strong
predictor
transloc
exampl
includ
investig
spd
variat
copd
asthma
cf
studi
rabbit
human
provid
evid
molecular
sizedepend
clearanc
protein
air
space
lung
howev
although
highli
anticip
studi
conclus
confirm
lmw
spd
transloc
lung
blood
easili
hmw
spd
figur
herbein
wright
report
spd
clearanc
lavag
elev
lpstreat
lung
compar
control
lung
due
increas
spd
uptak
tissu
neutrophil
clearanc
may
also
contribut
decreas
alveolar
spd
level
diseas
interpret
quantit
spd
alveolar
fluid
serum
variou
pulmonari
diseas
may
hamper
antispd
antibodi
may
vari
affin
oxid
andor
crosslink
speci
recent
discuss
atochinavasserman
hmw
lmw
spd
structur
variant
examin
bal
nativ
gel
electrophoresi
variou
clinic
pulmonari
diseas
describ
differ
studi
demonstr
level
trimer
spd
increas
bal
inflammatori
diseas
trimer
spd
compos
partial
degrad
oxid
inact
spd
well
variant
kda
presenc
snospd
bal
clinic
relev
sampl
recent
demonstr
snospd
indirectli
identifi
bal
patient
syndrom
type
directli
detect
sampl
asthmat
patient
segment
challeng
allergen
henc
role
snospd
diseas
marker
conceiv
enrich
bal
patient
pulmonari
diseas
elisabas
method
measur
circul
snospd
copd
patient
develop
use
antispd
captur
antibodi
antibodi
react
snitrosyl
group
detect
howev
approach
identifi
associ
diseas
sever
found
weak
correl
radiologist
score
emphysema
possibl
associ
diseas
activ
verifi
nevertheless
detect
circul
snospd
addit
pulmonari
diseas
warrant
similar
elisabas
approach
appli
measur
fucosyl
spd
demonstr
presenc
corefucos
nglycan
group
serum
spd
associ
circul
level
fucosyl
spd
copd
outcom
modif
repres
promis
circul
diseaseassoci
spd
biomark
candid
although
initi
experi
measur
level
fucosyl
spd
could
adequ
separ
neversmok
copd
smoker
copd
altern
approach
simpl
sdspagebas
measur
spd
degrad
product
bal
serum
permeat
chromatographybas
size
separ
howev
techniqu
may
bias
genet
size
variant
encod
oxid
crosslink
moreov
enzymat
neutrophil
elastas
degrad
spd
consecut
product
monoclon
antibodi
proteolysi
product
appear
result
immunolog
recognit
diseasespecif
spd
breakdown
product
although
variou
proteas
known
degrad
spd
approach
yet
develop
suffici
enabl
detect
diseaseinduc
spd
neoepitop
fetus
carri
sftpd
allel
associ
spontan
preterm
birth
initi
genet
associ
spd
pulmonari
outcom
prematur
infant
suggest
observ
spdspa
haplotyp
includ
allel
spd
variant
protect
develop
rd
harm
bpd
respect
subsequ
polymorph
locat
downstream
sftpd
demonstr
associ
rd
requir
oxygen
supplement
day
proxi
mild
bpd
earli
preterm
birth
infant
wherea
sftpd
snp
includ
associ
either
rd
bpd
studi
subsequ
investig
similar
tendenc
observ
anoth
studi
although
genet
spd
variant
appear
protect
bpd
defin
radiolog
requir
supplement
oxygen
gestat
age
week
recent
studi
sever
snp
sftpd
includ
variant
found
posit
associ
circul
spd
level
harm
respiratori
distress
requir
oxygen
supplement
day
respiratori
support
although
gener
conflict
data
studi
support
contribut
spd
genet
variat
pulmonari
outcom
prematur
discrep
studi
may
explain
differ
statist
power
differ
mean
gestat
age
associ
variat
requir
oxygen
supplement
day
investig
snp
haplotyp
may
reflect
variat
caus
variant
associ
sftpd
allel
neonat
mortal
identifi
may
explain
persist
highfrequ
snp
associ
respiratori
outcom
prematur
associ
identifi
spd
snp
variat
diffus
lung
diseas
enrich
genet
surfact
dysfunct
surfact
protein
express
fetal
distal
airway
increas
advanc
gestat
evid
fetus
howev
lung
infant
rd
bpd
open
termin
airway
border
spd
express
injur
area
line
hyalin
membran
alveoli
fill
hemorrhag
infect
edema
fluid
lightli
stain
unstain
wherea
serou
cell
bronchial
tracheal
gland
consist
stain
particularli
infant
lung
inflamm
percentag
multimer
spd
neonat
bal
capabl
bind
microbi
compound
appear
lower
preterm
term
infant
alveolar
spd
may
essenti
absent
presenc
rd
increas
surfact
treatment
howev
increas
preterm
bal
spd
first
day
day
birth
demonstr
parallel
transient
increas
capillari
spd
level
transient
circulatori
increas
predominantli
observ
infant
homozyg
allel
appar
infant
respiratori
distress
receiv
respiratori
support
observ
suggest
genet
spd
variat
determin
magnitud
induct
respiratori
supportdepend
system
spd
level
serum
spd
level
significantli
affect
antenat
steroid
posit
associ
gestat
age
mode
deliveri
risk
later
septicemia
risk
respiratori
distress
recent
studi
correl
serum
spd
measur
later
time
point
day
day
birth
preterm
infant
found
relat
requir
mechan
ventil
oxygen
develop
bpd
use
approach
mous
fetal
pulmonari
spd
express
increas
advanc
gestat
level
predominantli
elev
shortli
birth
stimul
vascular
endotheli
growth
factor
signal
glucocorticoid
treatment
pulmonari
spd
express
therefor
low
experiment
prematur
howev
variou
studi
lung
phenotyp
support
role
spd
normal
fetal
postnat
lung
develop
although
vast
accumul
phospholipid
lung
effect
surfact
homeostasi
rather
studi
support
role
spd
emphysema
fibrosi
develop
airway
remodel
process
later
life
recent
review
bersani
et
al
earli
studi
baboon
show
express
protein
secret
pulmonari
spd
preced
spa
normal
gestat
develop
baboon
compar
exceed
adult
level
advanc
gestat
age
line
observ
induct
circul
spd
respiratori
support
data
prematur
baboon
receiv
oxygen
day
produc
chronic
lung
injuri
indic
lavag
concentr
spa
reach
low
percentag
normal
adult
spd
equal
amount
present
normal
adult
combin
lavag
spaspd
pool
reach
low
percentag
normal
adult
author
conclud
combin
decreas
concentr
surfact
hostdefens
protein
may
augment
procliv
infect
worsen
injuri
suggest
partli
support
subsequ
experi
demonstr
increas
tendenc
lung
infect
model
howev
major
experiment
effect
relat
massiv
deplet
spa
surprisingli
mice
resist
hyperoxia
may
partli
explain
phospholipid
spbmediat
induct
surfact
resist
inactiv
consist
clinic
lung
matur
major
effect
experiment
chorioamnion
fetal
lung
inflamm
increas
airway
surfact
increas
lung
volum
proinflammatori
stimulu
chorioamnion
also
commonli
associ
preterm
deliveri
subsequ
rd
clinic
studi
support
associ
increas
spd
amniot
fluid
intraamniot
infect
contrast
studi
mice
lamb
demonstr
clear
induct
spd
express
fetal
lung
lp
treatment
although
earlier
studi
indic
greater
fluctuat
spd
express
furthermor
studi
use
transgen
mice
overexpress
rat
spd
spc
promot
demonstr
spd
enhanc
cytokin
product
fetal
matern
compart
matern
lp
exposur
moreov
significantli
higher
proport
pup
born
dam
overexpress
spd
stillborn
lp
treatment
compar
wildtyp
mice
moreov
mice
doubli
defici
spd
spa
delay
parturit
decreas
express
inflammatori
contractil
gene
recent
studi
extend
find
demonstr
femal
mice
fertil
defect
evidenc
smaller
litter
size
increas
preimplant
embryo
loss
elev
uterin
inflamm
mate
wildtyp
male
howev
support
previou
find
matern
lp
administr
result
increas
embryo
loss
proinflammatori
respons
femal
contrast
surpris
associ
high
intraamniot
spd
preterm
birth
addit
recombin
human
spd
commerci
surfact
contain
spb
spc
alon
improv
surfact
function
protect
prematur
lung
ventilationinduc
inflamm
increas
resist
protein
inhibit
surfact
function
chang
biophys
properti
structur
test
lamb
shortli
birth
although
pulmonari
inflamm
block
spd
exogen
spd
effect
model
endotoxin
shock
newborn
preterm
lamb
intratrach
administr
prevent
system
inflamm
decreas
cytokin
express
spleen
liver
although
structur
spd
polymorph
associ
allerg
bronchial
asthma
associ
decreas
atopi
identifi
black
subject
sever
studi
document
induct
bal
system
spd
level
asthma
may
attribut
combin
induc
spd
synthesi
airway
epithelia
increas
barrier
integr
describ
ealier
level
spd
increas
bal
sampl
allerg
asthma
patient
may
increas
segment
allergen
challeng
correl
bal
eosinophil
turn
correl
content
bal
oxid
spd
speci
baselin
spd
level
elev
serum
patient
allerg
asthma
elev
allergen
challeng
predict
late
asthmat
respons
eosinophil
cation
protein
concentr
postchalleng
recent
studi
support
initi
observ
demonstr
sputum
spd
increas
sever
asthma
sever
exacerb
serum
spd
increas
stepwis
mild
moder
sever
diseas
correl
invers
lung
function
directli
small
airway
resist
mackay
et
al
demonstr
serum
spd
increas
sever
asthma
mix
eosinophil
neutrophil
inflamm
enrich
spd
breakdown
product
latter
observ
support
recent
find
fakih
et
al
significantli
decreas
hmwlmw
serum
spd
ratio
asthmat
patient
studi
mackay
et
al
balserum
spd
ratio
report
decreas
implic
deplet
spd
bal
due
leakag
degrad
spd
serum
furthermor
serum
spd
level
invers
associ
alveolar
neutrophil
infiltr
alveolar
endotoxin
level
investig
support
relationship
asthma
spd
variat
includ
one
earliest
studi
serum
spd
recent
studi
serum
spd
akiki
et
al
discrep
may
explain
differ
distribut
mild
sever
asthma
investig
serum
spd
enrich
observ
pulmonari
allergi
allerg
rhiniti
consid
manifest
underli
diseas
process
asthma
basic
research
demonstr
link
spd
helper
cell
mediat
inflamm
thu
differ
clinic
observ
may
also
due
lack
stratif
differ
distribut
allerg
asthma
asthma
character
profil
account
approxim
patient
steroid
asthma
impact
neutrophil
inflamm
pathogen
load
implic
observ
mackay
et
al
allerg
asthma
model
provid
insight
physiolog
influenc
spd
develop
type
allerg
asthma
use
mice
allerg
asthma
model
provid
clear
subtl
allerg
asthma
phenotyp
howev
uniform
data
obtain
studi
use
exogen
administr
spd
larg
bodi
studi
use
rfhspd
treatment
protocol
although
rfhspd
effici
aggreg
opson
pollen
grain
rel
nativ
spd
spd
rfhspd
appear
dampen
major
aspect
allerg
phenotyp
intranas
administr
spdrfhspd
murin
model
pulmonari
hypersensit
induc
divers
allergen
antigen
suppress
specif
ige
level
serum
reduc
peripher
pulmonari
eosinophilia
caus
helper
cell
polar
allerg
inflamm
vari
degre
one
model
benefici
effect
exogen
spd
observ
administ
h
h
allergen
challeng
singl
applic
rfhspd
allergensensit
mice
led
dampen
allerg
airway
respons
equilibrium
similar
effect
budesonid
moreov
allergen
exposur
induc
spd
protein
level
manner
result
increas
murin
alveolar
spd
level
neg
feedback
loop
appear
protect
airway
inflammatori
damag
allergen
inhal
describ
recent
review
spd
lavag
tissu
deriv
atii
cell
club
cell
howev
also
synthes
hyperplast
goblet
cell
inflam
lung
addit
benefici
spd
effect
asthma
may
anticip
virusinduc
asthma
antivir
effect
spd
howev
deleteri
effect
may
also
expect
due
diseaseinduc
format
snospd
diseaserel
proteolysi
suspect
render
fraction
spd
malfunct
deleteri
nevertheless
overal
effect
spd
appear
benefici
context
allerg
asthma
main
report
individu
step
lead
spddepend
experiment
phenotyp
illustr
figur
effect
illustr
figur
remain
unclear
spd
increas
pollen
starch
granul
psg
posit
cell
vitro
acceler
psg
bindinguptak
vivo
howev
studi
winkler
et
al
demonstr
affect
total
clearanc
psg
mous
lung
enhanc
tcell
prolifer
induc
psgposit
dendrit
cell
henc
differ
result
obtain
use
human
cell
cultur
clinic
isol
cell
compar
mice
model
requir
investig
wider
role
spd
immun
recent
propos
studi
infect
helminth
nippostrongylu
brasiliensi
elev
spd
product
immun
partli
driven
turn
spd
exert
neg
feedback
control
respons
howev
wherea
allerg
asthma
studi
identifi
increas
type
immun
mice
similar
effect
observ
n
brasiliensi
infect
result
investig
demonstr
elev
spd
enhanc
type
immun
suggest
spd
import
modul
protect
produc
type
innat
lymphoid
cellmedi
alveolar
macrophag
respons
n
brasiliensi
associ
polymorph
haplotyp
flank
sftpd
copd
emphysema
copd
surviv
identifi
variou
popul
gwa
studi
review
lockjohansson
et
al
specif
snp
associ
valid
investig
popul
snp
associ
copd
circul
spd
level
differ
within
investig
suggest
distinct
genet
influenc
copd
suscept
spd
level
addit
two
code
snp
sftpd
associ
expiratori
lung
function
studi
preclin
smokeinduc
lung
injuri
suggest
structur
variant
spd
affect
suscept
copd
develop
smoker
recent
mendelian
random
analys
use
analyz
serum
spdassoci
genet
variant
associ
copd
largest
studi
execut
today
variant
test
associ
copd
risk
case
control
year
declin
lung
function
individu
studi
conclud
variant
associ
increas
serum
spd
level
decreas
risk
copd
slow
lung
function
declin
major
studi
smoker
report
reduc
alveolar
level
spd
alveolar
epitheli
injuri
lp
instil
sever
smoker
nonsmok
increas
circulatori
spd
decreas
bal
spd
clinic
observ
support
vitro
observ
nicotin
caus
reduc
level
spd
human
airway
epitheli
cell
addit
studi
demonstr
increas
circul
spd
tobacco
smoke
type
noxiou
exposur
includ
data
twin
studi
show
smoke
monozygot
twin
markedli
increas
serum
spd
rel
nonsmok
twin
despit
high
herit
serum
spd
level
howev
smokeinduc
serum
level
may
clearli
evid
mix
popul
respiratori
patient
spd
level
may
influenc
process
describ
earlier
cigarett
smoke
disrupt
quaternari
structur
spd
molecul
howev
initi
attempt
construct
immunoassay
proteolyt
spd
breakdown
product
serum
provid
addit
inform
regard
copd
whether
spd
level
differenti
copd
smoke
respiratori
diseas
uncertain
studi
note
signific
decreas
spd
bal
sampl
copd
patient
compar
current
smoker
other
multicent
studi
evalu
copd
longitudin
identifi
predict
surrog
endpoint
eclips
approxim
individu
copd
higher
serum
spd
level
report
among
copd
patient
rel
current
former
smoker
without
respiratori
obstruct
largest
differ
serum
spd
level
occur
nonsmok
currentform
smoker
conclud
spd
power
biomark
smoke
howev
differ
serum
spd
level
individu
copd
smoker
control
chronic
bronchiti
compar
symptom
addit
exampl
smaller
studi
shown
signific
differ
copd
smoker
control
smoker
chronic
obstruct
pulmonari
diseas
heterogen
diseas
sever
featur
overlap
asthma
import
therapeut
implic
patient
data
random
control
trial
inhal
glucocorticoid
therapi
copd
groningen
leiden
univers
chronic
obstruct
pulmonari
diseas
confirm
alter
airway
gene
express
may
coexist
asthma
copd
suggest
inflamm
import
subset
patient
copd
histori
asthma
despit
vast
bodi
experiment
evid
role
spd
eosinophilmedi
allergyasthmat
diseas
report
evid
link
chang
spd
expressionfunct
eosinophil
activ
copd
howev
independ
studi
provid
evid
support
elev
circul
spd
copd
compar
asthma
patient
thu
spd
may
differenti
two
diseas
yet
studi
may
control
suffici
effect
smoke
sever
asthma
size
separ
hmw
lmw
serum
spd
appear
provid
clear
distinct
control
copd
subject
hmwlmw
ratio
significantli
decreas
copd
control
smoke
addit
confound
howev
similar
associ
evid
asthmat
patient
addit
studi
suggest
smokingrel
spd
variat
prognost
lung
cancer
eclips
studi
serum
spd
level
associ
copd
diseas
sever
defin
global
initi
chronic
obstruct
lung
diseas
statu
associ
forc
expiratori
lung
function
smaller
studi
report
similar
find
howev
ju
et
al
report
associ
bode
bodymass
index
airflow
obstruct
dyspnea
exercis
index
sever
contradict
data
regard
associ
circul
spd
expiratori
lung
function
discrep
indic
may
invers
correl
serum
spd
forc
expiratori
lung
function
smoker
without
copd
correl
may
difficult
identifi
cohort
includ
smoker
nonsmok
two
group
exhibit
opposit
associ
spd
variat
addit
correl
may
also
affect
differ
copd
treatment
recent
analysi
data
independ
longitudin
populationbas
cohort
suggest
larg
proport
individu
develop
airflow
limit
exhibit
rapid
declin
forc
expiratori
volum
normal
level
lung
function
earli
adulthood
wherea
anoth
fraction
rel
gradual
rate
declin
start
low
initi
valu
regard
circul
spd
suggest
provid
mean
identifi
smoker
low
initi
lung
function
highest
risk
copd
develop
thu
elig
earli
intervent
pharmacolog
treatment
addit
recommend
tobaccosmok
cessat
nevertheless
longitudin
studi
warrant
valid
use
spd
measur
inform
complementari
spirometr
test
earli
detect
surfact
protein
rather
stabl
marker
measur
repeatedli
within
month
nevertheless
sin
et
al
report
signific
associ
serum
spd
declin
dyspnea
improv
within
studi
inhal
corticosteroid
ic
icslongact
beta
agonist
combin
prednisolon
also
report
significantli
reduc
plasma
concentr
spd
report
chang
spd
level
associ
symptom
score
contrast
ic
use
independ
associ
higher
spd
level
bal
atii
cell
isol
adult
rat
lung
respond
dexamethason
treatment
significantli
increas
spd
howev
studi
valid
spd
marker
copd
treatment
increas
level
circul
spd
report
exacerb
copd
compar
stabl
copd
observ
crosssect
studi
extend
longitudin
studi
demonstr
level
circul
spd
decreas
week
hospit
due
exacerb
ultim
increas
month
hospit
variat
level
onset
exacerb
appear
mirror
white
blood
cell
count
ascrib
effect
glucocorticoid
treatment
chronic
obstruct
pulmonari
diseas
subject
eclips
cohort
well
cohort
highest
serum
spd
concentr
baselin
also
increas
risk
exacerb
followup
period
eclips
consortium
subsequ
perform
detail
analysi
conclud
associ
spd
level
persist
adjust
histori
exacerb
overal
report
data
indic
spd
robust
marker
treatment
effect
util
circul
spd
marker
predict
copd
exacerb
may
limit
despit
induct
serum
spd
acut
phase
data
analys
eclips
cohort
demonstr
baselin
serum
spd
level
associ
baselin
lung
densiti
declin
time
howev
correl
spd
emphysema
recent
challeng
observ
serum
spd
variat
smoke
pulmonari
emphysema
combin
pulmonari
fibrosi
emphysema
cpfe
serum
spd
clearli
induc
cpfe
group
compar
group
moreov
studi
indiumexpos
worker
demonstr
increas
serum
spd
close
associ
progress
interstiti
chang
progress
emphysema
eclips
consortium
subsequ
confirm
copd
highli
heterogen
diseas
poor
correl
symptom
qualiti
life
function
outcom
biomark
gener
highlight
need
patient
subgroup
consortium
includ
serum
spd
multimark
cluster
analysi
copd
subgroup
found
reduc
among
individu
sever
emphysema
higher
among
progress
emphysema
result
data
suggest
highcircul
spd
level
could
indic
highli
activ
diseas
progress
wherea
low
level
may
reflect
loss
lung
tissu
thu
sever
emphysema
author
conclud
implic
spd
appear
differ
cluster
cluster
furthermor
eclips
copdgen
multicent
cohort
studi
indic
combin
multipl
biomark
includ
spd
much
strongli
predict
airflow
limit
emphysema
mortal
individu
biomark
howev
amount
varianc
explain
multipl
biomark
lower
clinic
variabl
togeth
observ
circul
spd
associ
hard
endpoint
allcaus
mortal
copd
relationship
treatment
effect
invers
correl
smoker
indic
spd
use
copd
marker
within
specifi
prognost
subgroup
multimark
analys
multimark
analys
includ
spd
may
use
limit
clinic
trial
subgroup
patient
like
benefit
given
intervent
serv
surrog
endpoint
semiquantit
studi
age
mice
indic
develop
progress
emphysema
increas
septal
wall
thick
subpleur
fibrosi
may
indic
phenotyp
combin
emphysemat
fibrot
chang
lung
highli
detail
stereolog
investig
longterm
progress
lung
parenchym
remodel
destruct
septal
wall
thicken
age
mice
recent
undertaken
schneider
et
al
investig
conclud
unchalleng
age
pulmonari
phenotyp
character
airspac
enlarg
without
septal
wall
thicken
fibrosi
destruct
emphysema
ageinduc
airway
enlarg
suggest
result
unexplain
alter
airway
mechan
author
suggest
discrep
observ
previou
studi
might
partli
result
differ
genet
background
mous
strain
use
ongo
alveolar
mice
although
role
spd
spontan
airway
remodel
recent
question
sever
studi
mice
challeng
noxiou
stimuli
provid
clear
evid
role
spd
pulmonari
inflamm
emphysema
develop
essenti
compon
copd
pathophysiolog
result
support
role
spd
modul
alveolar
macrophag
activ
oxid
product
mmp
activ
lead
emphysemalik
fibrot
chang
lung
histolog
morphometr
studi
demonstr
airspac
enlarg
andor
emphysema
develop
associ
sftpd
defici
inflammatori
structur
chang
may
revers
prevent
local
treatment
rfhspd
fulllength
spd
chang
appear
predominantli
affect
alveolar
compart
appar
spddepend
effect
vascular
physiolog
cigarett
smoke
exposur
contrast
find
human
copd
mice
neutrophil
infiltr
associ
lung
remodel
emphysema
develop
moreov
alveolar
level
spd
mice
rat
may
increas
pulmonari
exposur
noxiou
stimuli
contrast
major
find
human
howev
reduct
spd
rat
bal
exposur
noxiou
stimuli
report
viral
bacteri
respiratori
tract
infect
amplifi
chronic
inflamm
copd
trigger
pathogenrecognit
receptor
recent
review
brussel
et
al
addit
benefici
spd
effect
copd
develop
progress
may
anticip
due
antivir
antibacteri
effect
spd
main
individu
step
contribut
spddepress
experiment
phenotyp
relev
copd
illustr
figur
phenotyp
mice
defici
propos
spd
receptor
highli
similar
report
mice
includ
alveolar
enlarg
enhanc
ro
product
accumul
foami
macrophag
enhanc
express
surfact
lipid
chang
induc
spd
may
attribut
effect
alveolar
type
ii
cell
activ
although
defici
also
caus
emphysemalik
phenotyp
associ
alveolar
macrophag
activ
phenotyp
neither
sftpddefici
mice
fulli
reflect
human
copd
mous
alveolar
macrophag
becom
foami
lipidladen
phagosom
due
extens
uptak
surfact
lipid
howev
human
patholog
foami
macrophag
found
divers
disord
includ
diffus
panbronchiol
bronchiol
associ
bronchiecstasi
diseas
surfact
homeostasi
extrins
allerg
alveol
tuberculosi
rather
copd
moreov
alveolar
accumul
surfact
lipid
two
type
gene
defici
appear
reflect
aspect
pulmonari
alveolar
lipoproteinosi
deriv
defect
granulocyt
macrophag
colonystimul
factor
signal
type
macrophag
exhaust
thu
appear
foami
macrophag
lung
may
specif
copdrel
process
although
induct
foami
macrophag
result
exposur
mice
cigarett
smoke
foami
macrophag
provid
sourc
ro
inflammatori
signal
mous
model
result
sftpd
defici
recent
studi
constitut
circul
spd
measur
elderli
twin
popul
subclin
diseas
like
present
demonstr
relationship
highest
spd
level
increas
allcaus
mortal
femal
twin
highest
spd
level
significantli
increas
risk
die
cotwin
studi
followup
period
adjust
analysi
intrapair
differ
smoke
packyear
affect
associ
indic
spd
mere
proxi
smoke
reflect
mortal
studi
dementia
elderli
reach
similar
conclus
associ
allcaus
mortal
without
genderbia
henc
possibl
spd
associ
cvd
number
one
caus
death
sourc
circul
spd
entir
clear
possibl
spillov
spd
diseas
arteri
wall
circul
may
affect
total
serum
level
addit
lung
main
contributor
copd
coronari
arteri
diseas
cad
frequent
coexist
copd
independ
risk
factor
cad
increas
risk
cardiovascular
mortal
patient
diagnos
treat
copd
increas
risk
hospit
death
due
cvd
correl
suggest
associ
spd
allcaus
mortal
may
rather
complex
recent
studi
demonstr
spd
level
correl
alveolar
leakag
heart
failur
presenc
submass
pulmonari
embol
support
hypothesi
variat
circulatori
spd
result
diseasemedi
lung
damag
type
cvd
recent
obtain
data
indic
nomin
associ
sftpd
code
variant
includ
polymorph
subclin
atherosclerosi
demonstr
direct
effect
depend
tobacco
smoke
independ
circul
spd
level
addit
studi
identifi
borderlin
signific
associ
polymorph
advanc
atherosclerosi
variat
observ
significantli
contribut
risk
arteri
stenosi
includ
complex
model
inflammatori
gene
variant
suggest
innat
immun
factor
includ
spd
may
provid
link
respiratori
vascular
morbid
mortal
context
circul
spd
posit
associ
allcaus
mortal
cardiovascular
mortal
larg
studi
vancouv
coronari
angiographi
cohort
hill
et
al
inclus
spd
multimark
analysi
improv
risk
predict
across
level
risk
also
signific
posit
associ
spd
tripl
vessel
diseas
borderlin
associ
total
cholesterol
howev
associ
serum
lipid
fraction
diabet
mellitu
observ
studi
spd
also
associ
allcaus
mortal
eclips
copd
cohort
describ
studi
relationship
among
copd
coronari
arteri
calcif
mortal
use
cohort
circulatori
spd
correl
agatston
score
relationship
spd
cvd
support
observ
hu
et
al
posit
associ
circulatori
spd
level
carotid
arteri
intimamedia
thick
sever
coronari
arteri
calcif
persist
multivari
adjust
hill
et
al
hu
et
al
report
bal
spd
mean
monitor
presenc
lung
diseas
therefor
address
question
organ
sourc
circulatori
spd
surfact
protein
express
well
express
spdreceptor
oscar
induc
secret
inflammatori
monocyt
expos
spd
local
tunica
intima
tunica
media
clinic
atherosclerot
plaqu
arteri
spd
express
document
endotheli
cell
coronari
smooth
muscl
cell
pattern
express
regul
implic
spd
modul
inflamm
induc
spd
express
cell
type
direct
interact
lmw
hmw
spd
hdl
ldl
oxldl
demonstr
use
elisabas
assay
observ
suggest
domin
effect
spd
vasculatur
may
multival
interact
microb
rather
may
includ
special
lmw
spdmediat
effect
lipid
metabol
spd
receptor
oscar
express
cell
type
relev
atherogenesi
includ
monocyt
cell
neutrophil
dendrit
cell
endotheli
cell
sftpd
defici
shown
protect
dietinduc
atherosclerosi
model
mice
endogen
spd
influenc
system
plasma
lipid
inflamm
reduc
hdl
cholesterol
triglycerid
level
increas
mice
maintain
long
term
cholaterich
diet
intraven
treatment
rfhspd
day
result
reduct
hdl
cholesterol
also
parallel
ldl
cholesterol
total
cholesterol
effect
triglycerid
role
spdmediat
modul
plasma
lipid
atherogenesi
thu
uncertain
howev
longterm
effect
event
studi
subsequ
studi
use
doubledefici
apolipoprotein
e
apo
mice
show
similar
quantit
effect
decreas
lesion
size
moreov
sftpd
defici
result
less
macrophag
accumul
smooth
muscl
cell
coverag
lesion
studi
endogen
spd
reduc
sever
plasma
lipid
fraction
includ
total
cholesterol
induc
circulatori
rather
contrast
two
previou
studi
studi
use
doubledefici
ldlreceptor
ldlr
mice
provid
clear
evid
role
spd
atherogenesi
sorensen
unpublish
data
bridg
et
al
report
spd
potent
inhibitor
oxid
ldl
oxldl
vitro
assay
later
ascrib
major
effect
residu
edta
spd
vehicl
publish
erratum
howev
consequ
sftpd
defici
atherogenesi
may
also
result
antioxid
effect
spd
effect
format
ro
nomedi
signal
although
aspect
investig
detail
vascular
system
potenti
link
low
spd
level
sequela
atherosclerosi
recent
demonstr
use
cerebrospin
fluid
sampl
patient
cerebr
infarct
almost
simultan
mous
model
cerebr
ischemia
analyz
show
effect
sftpd
defici
howev
model
base
perman
occlus
middl
cerebr
arteri
involv
atherosclerosi
main
report
individu
step
lead
spdenhanc
experiment
outcom
relev
atherosclerosi
illustr
figur
addit
associ
spd
cvd
possibl
caus
associ
circul
spd
allcaus
mortal
may
includ
role
spd
metabol
homeostasi
describ
earlier
brain
pancrea
gut
endothelium
express
spd
locat
suggest
potenti
effect
system
metabol
diabet
metabol
syndrom
frequent
comorbid
copd
patient
copd
diabet
metabol
syndrom
relat
system
inflamm
may
explain
cooccurr
moreov
pulmonari
function
impair
well
recogn
diabet
may
attribut
increas
pulmonari
bacteri
colon
due
hyperglycemia
exacerb
copd
among
addit
caus
recent
discuss
kinney
et
al
contrast
reduc
abil
erad
pathogen
may
caus
frequent
respiratori
tract
infect
chronic
inflamm
result
insulin
resist
type
diabet
review
pickup
moreov
cigarett
smoke
independ
predictor
type
diabet
although
link
lower
vital
capac
diabet
risk
independ
cigarett
exposur
stronger
neversmok
obes
frequent
caus
insulin
resist
although
impair
lung
function
present
develop
metabol
syndrom
diabet
associ
pulmonari
metabol
impair
may
least
partli
result
effect
obes
recent
shown
longitudin
strong
heart
studi
multipl
cellular
molecular
mechan
innat
immun
system
may
contribut
relationship
review
lackey
olefski
sever
studi
independ
identifi
posit
associ
lung
function
impair
full
metabol
syndrom
obes
metabol
biomark
predictor
impair
lung
function
respons
particul
inhal
overal
close
relationship
metabol
respiratori
impair
suggest
lung
innat
immun
infer
genet
phenotyp
spd
variat
could
resid
intersect
inflamm
obes
insulin
resist
multivari
genet
analysi
use
investig
genet
associ
serum
spd
factor
involv
metabol
syndrom
twin
studi
geminakar
studi
found
genet
correl
trait
differ
close
zero
spd
versu
bodi
mass
index
bmi
may
indic
common
genet
contribut
regul
trait
ie
pleiotropi
signific
limit
signific
genet
correl
serum
spd
hdl
cholesterol
total
cholesterol
studi
investig
possibl
genet
associ
spd
diabet
subsequ
studi
ortega
et
al
demonstr
common
snp
variant
sftpd
promotor
posit
associ
circul
spd
level
enrich
individu
lower
bmi
decreas
percentag
fat
mass
studi
pueyo
et
al
show
presenc
variant
spd
allel
increas
odd
develop
insulin
resist
type
diabet
especi
among
women
moreov
snp
other
sftpd
genom
region
significantli
associ
glucos
homeostasi
insulin
sensit
type
diabet
accord
gwa
dataset
associ
independ
circul
spd
concentr
borderlin
signific
invers
associ
observ
free
lp
concentr
plasma
circul
spd
subject
homozyg
homozyg
small
subpopul
studi
observ
indic
differ
genotyp
may
predispos
differ
buffer
capac
metabol
endotoxemia
consist
observ
lethlarsen
et
al
show
spd
bound
preferenti
lp
compar
spd
et
al
evalu
serum
spd
four
differ
cohort
found
spd
concentr
significantli
decreas
nonobes
popul
type
diabet
correl
sever
metabol
variabl
includ
bmi
fast
postload
glucos
level
obes
subject
show
significantli
decreas
serum
spd
concentr
weight
loss
led
significantli
decreas
serum
spd
concentr
serum
spd
concentr
significantli
associ
lung
function
paramet
studi
multipl
linear
regress
perform
use
data
subject
alter
glucos
toler
fast
glucos
fast
triglycerid
identifi
independ
contribut
spd
varianc
howev
recent
studi
et
al
demonstr
increas
serum
spd
diabet
obes
patient
type
diabet
moreov
serum
spd
popul
independ
invers
associ
obes
diabet
patient
author
conclud
serum
spd
might
use
biomark
detect
lung
impair
obes
patient
type
diabet
find
ortega
et
al
support
previou
observ
sftpd
express
human
adipos
tissu
adipocyt
express
decreas
oment
subcutan
adipos
tissu
obes
subject
without
type
diabet
compar
control
group
oment
spd
express
invers
associ
sever
metabol
variabl
includ
bmi
percentag
fat
mass
waist
circumfer
fast
glucos
posit
associ
express
insulin
receptor
substrat
fatti
acid
synthas
suggest
spd
may
effect
glucos
toler
fat
tissu
vice
versa
least
two
previou
studi
demonstr
decreas
constitut
circul
spd
obes
overweight
subject
correct
gender
smoke
age
may
support
initi
influenc
process
lead
accumul
fat
tissu
correl
spd
metabol
impair
part
danish
populationbas
twin
studi
metabol
syndrom
geminakar
serum
spd
identifi
significantli
invers
associ
weight
waist
circumfer
men
bmi
sex
similar
find
obtain
chines
populationbas
cohort
moreov
relationship
also
observ
patient
obes
ali
three
independ
studi
demonstr
link
sftpd
defici
obes
accord
studi
stidsen
et
al
bodi
mass
develop
sftpddefici
mice
significantli
increas
compar
correspond
wildtyp
mice
receiv
ad
libitum
fix
energi
intak
diet
studi
also
identifi
signific
redistribut
bodi
fat
parallel
obesityrel
insulin
resist
well
increas
metabol
endotoxemia
associ
sftpd
defici
model
rel
insulin
resist
sftpddefici
mice
later
valid
hirano
et
al
addit
link
spd
bodi
fat
mass
includ
observ
decreas
spd
express
human
adipos
tissu
increas
bmi
direct
spd
interact
fatti
acid
furthermor
spd
link
metabol
homeostasi
two
independ
studi
seek
identifi
gene
involv
cell
adapt
mous
pregnanc
rat
perinat
regener
pancrea
studi
demonstr
sftpd
mrna
protein
level
cell
exhibit
larg
transient
perinat
increas
express
spd
islet
demonstr
suggest
induct
spd
gener
effect
mani
cell
type
direct
role
spd
experiment
diabet
develop
demonstr
howev
develop
diabet
mother
rat
accompani
delay
pulmonari
histogenesi
decreas
spd
express
pup
moreov
viral
neutral
spd
vitro
abolish
presenc
glucos
level
commonli
found
diabet
mice
may
contribut
reduc
antivir
protect
diabet
widespread
spd
express
document
multitud
studi
underscor
fact
although
lung
remain
major
site
spd
synthesi
essenti
effect
spd
innat
immun
expect
numer
addit
site
variou
exampl
extrapulmonari
effect
investig
document
mani
year
research
spdmediat
immunemodul
primarili
focus
role
phagocytosi
efferocytosi
opson
oxid
signal
phagocyt
howev
analys
spd
interact
variou
white
blood
cell
epitheli
cell
fibrocyt
smooth
muscl
cell
provid
detail
insight
spdmodul
patholog
impli
addit
cellular
spdmediat
effect
remain
unexplor
exampl
includ
endotheli
cell
adipocyt
spd
express
report
effect
express
remain
larg
unknown
gap
knowledg
regard
role
spd
nonimmun
cell
level
express
spd
homeostasi
diseas
potenti
hamper
design
interpret
vivo
experi
clinic
biomark
studi
support
observ
spdinduc
cellular
signal
differ
spd
receptor
receptor
complex
identifi
howev
major
studi
suggest
new
spd
receptor
yet
valid
independ
research
major
report
pulmonari
effect
spd
signal
dampen
inflamm
pulmonari
suppress
inflamm
thu
document
outcom
appli
spd
rfhspd
treatment
despit
potenti
inflammatori
side
effect
spd
variant
unabl
form
hmw
spd
due
modif
may
repres
proteolyt
breakdown
product
lowmolecular
weight
spd
character
preferenti
bind
lp
circul
lipoprotein
compar
hmw
spd
howev
effect
pro
antiinflammatori
cellular
signal
result
recognit
complex
explor
moreov
unknown
degre
interact
spd
lp
lipoprotein
mediat
assembl
lmw
hmw
form
vivo
observ
immobil
mannac
ligand
vitro
howev
observ
suggest
differ
effect
lmw
spd
compar
hmw
spd
studi
previous
propos
role
collectin
quench
immuneactiv
effect
hydrophob
polym
lipid
cholesterol
lipoprotein
particl
warrant
particularli
lmw
spd
contrast
primarili
antiinflammatori
effect
spd
lung
develop
mous
atherosclerosi
major
impact
spd
appear
enhanc
inflamm
also
case
fetoplacent
develop
observ
could
potenti
explain
sitespecif
express
spd
receptor
determin
contribut
spdmediat
oscar
signal
respiratori
nonrespiratori
diseas
may
help
clarifi
reason
underli
conflict
observ
pro
antiinflammatori
effect
spd
pauciti
vivo
data
confirm
nativ
spd
structur
size
variationdepend
effect
diseas
although
initi
attempt
made
use
mice
overexpress
common
human
sftpd
variant
determin
effect
degre
spd
multimer
contrast
variou
studi
demonstr
treatment
lmw
rfhspd
molecul
may
rescu
histogenesi
mice
resolv
inflamm
sftpd
mice
suggest
particular
fragment
may
capabl
signal
set
cellular
receptor
endogen
spd
vivo
inflammatori
effect
may
amelior
high
local
concentr
spd
regardless
distribut
hmw
lmw
spd
howev
rfhspd
also
fail
demonstr
effect
sever
set
question
extent
effect
fulllength
multimer
spd
may
mimick
high
level
trimer
spd
yet
fulli
answer
degre
sftpd
variant
affect
spd
structur
size
diseas
also
remain
elucid
nevertheless
polymorph
affect
degre
multimer
nondiseas
popul
also
identifi
associ
numer
respiratori
diseas
well
cvd
metabol
diseas
sftpd
associ
diseas
may
indic
expression
level
spd
also
abil
form
multim
essenti
spdmediat
effect
beyond
interact
multival
ligand
clearanc
thereof
overal
major
data
genet
studi
particular
polymorph
indic
associ
allel
divers
clinic
condit
howev
allel
also
report
protect
diseas
includ
sever
respiratori
syncyti
viru
infect
caus
infant
death
allel
observ
rel
high
frequenc
lung
among
five
largest
organ
human
bodi
spd
concentr
alveolar
line
fluid
appear
higher
rel
circul
level
thu
loss
barrier
integr
respiratori
diseas
may
caus
pulmonari
spd
transloc
lead
increas
system
level
despit
huge
variat
constitut
level
clinic
spd
defici
document
howev
bal
level
spd
may
decreas
respiratori
diseas
level
allow
immunodetect
circulatori
level
rise
howev
conclus
confirm
lmw
spd
transloc
lung
blood
easili
hmw
spd
two
studi
confirm
increas
level
circul
lmw
spd
respiratori
diseas
transloc
spd
appear
reflect
chang
ratio
bal
spd
circul
spd
ratio
effect
differenti
respiratori
case
control
smoker
alway
possibl
use
isol
serum
bal
measur
howev
due
invas
natur
sampl
spd
measur
bal
provid
use
mean
diseas
monitor
attempt
monitor
lmw
spd
breakdown
product
spd
report
primarili
reli
use
nativ
gel
electrophoresi
may
applic
largescal
analysi
develop
immunoassaybas
method
previous
use
detect
circul
extracellular
matrix
epitop
warrant
studi
spd
diseas
biomark
whether
particular
lmw
spd
speci
enrich
lung
organ
requir
explor
import
inform
obtain
spd
variat
prematur
infant
includ
normal
rang
spd
term
preterm
newborn
influenc
perinat
factor
howev
pauciti
independ
studi
valid
observ
associ
highest
serum
spd
level
measur
day
birth
sever
outcom
prematur
infant
warrant
valid
recent
research
find
support
increas
circul
spd
moder
sever
asthma
addit
allerg
rhiniti
yet
spd
breakdown
product
also
enrich
blood
system
sever
asthma
indic
fragment
may
provid
specif
measur
diseas
activ
although
spd
level
highli
increas
respons
smoke
highest
circul
spd
level
appear
proxi
smoke
also
relat
diseas
outcom
adjust
smoke
henc
provid
robust
marker
treatment
effect
associ
mortal
identifi
cvd
cohort
select
select
copd
presenc
cvd
thu
anticip
signific
contributor
induct
circul
spd
level
copd
author
eclips
studi
stress
divis
copd
popul
homogen
subgroup
similar
prognos
provid
potenti
test
intervent
studi
underscor
monitor
biomark
array
includ
spd
use
indic
diseas
prognosi
predict
monitor
clinic
respons
intervent
howev
strategi
yet
valid
random
clinic
trial
gener
appear
untap
potenti
monitor
circul
lmw
spd
spd
neoepitop
aim
separ
diseas
case
control
well
use
diseas
prognosi
specif
proteas
known
degrad
spd
aspect
yet
pursu
suffici
identifi
diseaseinduc
spd
neoepitop
elabor
immunoassaybas
method
previous
use
detect
circul
extracellular
matrix
epitop
warrant
studi
spd
breakdown
product
variat
respiratori
well
nonrespiratori
diseas
experiment
data
support
presenc
circul
breakdown
product
approach
potenti
provid
measur
diseas
organ
specif
spd
breakdown
product
remain
determin
whether
subject
present
highest
circul
spd
level
prone
develop
clinic
diseas
due
presenc
preclin
lung
injuri
cvd
monitor
spd
may
facilit
earli
intervent
circul
spd
confound
adipos
diabet
experiment
genet
link
establish
disord
howev
associ
explain
mechanist
correl
circul
spd
adipos
invers
may
therefor
counteract
phenotyp
associ
respiratori
diseas
cvd
pulmonari
instil
spd
benefici
exampl
preterm
ventil
lamb
repres
clinic
relev
model
preterm
surfact
need
also
allerg
asthma
model
smokeinduc
pulmonari
injuri
current
use
surfact
therapeut
formul
lack
spd
greatli
reduc
mortal
rd
signific
proport
patient
develop
oxygen
depend
ventilatori
requir
extend
beyond
first
week
life
especi
among
survivor
lowbirth
weight
extrem
prematur
use
preterm
lamb
model
treatment
effect
pronounc
anim
treat
surfact
enrich
spd
versu
receiv
surfact
alon
suggest
therapeut
potenti
use
spd
supplement
current
surfact
formul
treatment
neonat
rd
develop
bpd
merit
clinic
investig
multitud
vivo
data
support
benefici
effect
exogen
spd
treatment
allerg
asthma
pulmonari
infect
treatment
exogen
spd
may
dual
effect
asthma
target
inflamm
fibrot
develop
induc
antiinflammatori
effect
compar
obtain
treatment
budesonid
contrast
suppress
effect
mous
model
hous
dust
miteinduc
inflammatori
asthma
process
addit
exogen
spd
could
reduc
fibrot
deposit
hous
dust
mite
allergen
challeng
mice
administ
throughout
experiment
period
bleomycin
treatment
induct
pulmonari
fibrosi
howev
remain
seen
whether
exogen
administr
spd
attenu
fibrosi
wildtyp
mice
administ
fibrot
phase
experi
crucial
add
weight
potenti
spd
therapeut
intervent
allerg
asthma
respiratori
diseas
character
fibrot
deposit
includ
bpd
copd
idiopath
pulmonari
fibrosi
effect
exogen
spd
model
copd
atherosclerosi
requir
valid
independ
laboratori
mechanist
studi
howev
observ
basic
cardiovascular
studi
studi
metabol
suggest
system
side
effect
exogen
spd
treatment
includ
disturb
circul
lipoprotein
level
wholebodi
fat
distribut
observ
impli
local
administr
spd
treatment
respiratori
diseas
may
prefer
system
induct
spd
express
howev
understand
spd
may
also
harm
atherogenesi
infect
fetoplacent
develop
suggest
develop
pharmaceut
mean
induc
tissu
cell
typespecif
inhibit
spd
warrant
addit
potenti
treatment
suggest
includ
use
coval
bound
complex
compris
antibodi
crosslink
point
mutat
spd
introduct
specif
nlink
glycan
enhanc
antivir
antibacteri
therapi
exampl
genet
engin
spd
resist
proteolysi
relev
treatment
p
aeruginosa
reduct
lung
inflamm
injuri
allogen
hematopoiet
stem
cell
transplant
inclus
spd
nasal
spray
chronic
rhinosinus
polyp
allevi
pneumonia
sever
intestin
injuri
staphylococcu
aureu
pneumonia
pulmonari
aspergillosi
moreov
therapeut
approach
suggest
increas
transcript
spd
clinic
trial
treat
patient
recombin
spd
yet
undertaken
despit
bodi
preclin
data
support
signific
treatment
effect
nevertheless
earli
observ
recombin
spd
prevent
endotoxin
shock
preterm
lamb
pave
way
format
spinout
compani
cincinnati
children
hospit
medic
center
airway
therapeut
goal
produc
fulllength
recombin
spd
replac
protein
therapi
prevent
bpd
prematur
infant
product
receiv
orphan
design
statu
bpd
us
european
union
accord
websit
wearetechohioohiogov
current
advanc
preclin
develop
stage
gmpproduct
process
develop
investig
new
drugen
preclin
experi
conduct
although
airway
therapeut
focus
produc
fulllength
spd
may
close
conduct
trial
altern
approach
would
produc
rfhspd
synthes
escherichia
coli
rfhspdbase
treatment
secur
fund
continu
develop
professor
howard
clark
univers
southampton
honorari
consult
pediatr
southampton
univers
hospit
trust
person
commun
addit
intellectu
properti
right
product
fulllength
spd
rfhspd
treatment
prophylaxi
respiratori
diseas
patent
obtain
facilit
commerci
develop
spdbase
monitor
respiratori
diseas
pharmaceut
treatment
base
recombin
spd
fragment
thereof
nonexhaust
list
patent
patent
applic
cover
spd
marker
dyspnea
marker
steroid
respons
asthma
copd
glycyrrhetin
acid
reduct
spd
express
spd
modul
eosinophil
activ
combin
administr
lysozym
spd
respiratori
prophylaxi
recombin
chimer
spdantibodyfrag
protein
enhanc
neutrophil
uptak
pathogen
critic
step
futur
develop
spdbase
therapi
outcom
wellperform
clinic
trial
confirm
hypothesi
exogen
spd
improv
neonat
rd
bpd
result
trial
potenti
facilit
develop
test
spd
treatment
addit
divers
set
includ
fibrosi
lung
allerg
asthma
copd
gs
conceiv
draft
approv
final
version
manuscript
account
aspect
work
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
